What are biontech stock price predictions?

BioNTech stock price predictions for the next twelve month period range from a low of $126 to a high of $433. The analyst price target consensus is currently $272.31, approximately a 9% of potential upside on the current (16 November) share price.

Why did biontech (bntx) stock go up?

Shares of BioNTech (NASDAQ: BNTX) were up as by much as 5.3% on Friday before closing the session up 3.85% after the biotech company announced positive news regarding a clinical trial for its non-small cell lung cancer therapy candidate. The company focuses on immunotherapies to treat cancer, infectious diseases, and other diseases.

How did biontech perform in the third quarter of 2019?

BioNTech and Pfizer equally share in the gross profits associated with sales of their vaccine. BioNTech also reported a net income of 3.2 billion euros ($3.6 billion); it had recorded a net loss during the third quarter of 2019. Importantly, BioNTech ended the third quarter with 2.4 billion euros ($2.7 billion) in cash and cash equivalents.

Is pipeline risk a concern for biontech's stock?

Still, pipeline risk is likely to be an equally large concern, especially for investors who are considering purchasing the stock today. Particularly in BioNTech's oncology pipeline, there will soon be enough mid-stage clinical projects approaching critical readouts to make predicting the stock's price an exercise in futility.